2012 MedTech Events

Monthly Listing of Events

BioVenture Luncheon Series: Pre-Clinical Processes for Pharmaceutical Development

11/14/12 (W) 12:00 - 1:30 pm

Rochester BioVenture Center, 77 Ridgeland Road, Rochester, NY

The road to approval of a new drug involves advancing through several phases, and pre-clinical testing is one of the first major hurdles in determining whether a lead compound will proceed further on the path to reaching the market. Care in planning and executing the pre-clinical trials can help prevent rejection of viable leads as well as establish a firm foundation for those candidates that can proceed to the Investigational New Drug Application stage.

Are you looking for a research lab to collaborate on pre-clinical work? Calvert Labs will present a discussion of their laboratory services for pre-clinical testing of new drug and vaccine candidates, along with a presentation on the expanding pharmaceutical development at Bausch + Lomb.


Charles Spainhour,  V.M.D., Ph.D.
President and Chief Science Officer, Calvert Labs
Dr. Spainhour has over 30 years experience in the pharmaceutical industry he has written numerous papers, books and is an expert on regulatory compliance.  He also has worked at a number of companies from Pharmakon Research, Chrysalis International, Phoenix International Life Sciences and Smith Kline & French Laboratories (now GlaxoSmithKline Corporation).  He is a Diplomate American Board of Forensic Science, Diplomate American Board of Toxicology and Diplomate American Board of Forensic Medicine. 

Mary Richardson, PhD, DABT
Executive Director of Preclinical Develpoment, Bausch + Lomb
Ms. Richardson currently serves in the research and development of ocular pharmaceutical products at Bausch + Lomb. She works in Toxicology, Drug Metabolism and Pharmacokinetics, and prior to her role as executive director, she was a director of nonclinical safety.  Mary was with Proctor & Gamble before joining B+L.




A light lunch will be available

Registration closes November 13, 2012 at 5:00 pm!

Return to Top

BioVenture Luncheon Series | Medical Device Reimbursement Benchmarks and Strategies

10/10/12 (W) 12:00 - 1:30 PM

Rochester BioVenture Center, 77 Ridgeland Road, Rochester, NY

Understanding the processes for medical device reimbursements from health insurers is critical to determining addressable market adoption as well as planning sales and channel strategies for new medical devices.  Entrepreneurs need to consider this in planning product launches.  Medical device product managers and sales executives in existing companies can increase market adoption rates through addressing reimbursement issues as part of the pre-sale activities.

In this session you will learn about common issues related to medical device reimbursement and the strategies that have been employed to improve market success.


David Barone, Principal, Boston MedTech Advisors
David Barone held senior management positions in a number of medical device companies, overseeing product development, marketing, pilot manufacturing, clinical evaluations, regulatory affairs and intellectual properties. In addition, David is an accomplished entrepreneur, founding, financing and growing several healthcare service organizations.  He has assisted medical technology organizations, ranging from start-ups to Fortune 500 companies, in diverse areas including market development, opportunity analysis, regulatory and reimbursement strategies, business development, and financing.

Yossi Elaz, Boston MedTech Advisors
Yossi Elaz’s background includes senior executive management positions in large global medical device organizations, including Siemens Medical Systems, and most recently, a member of Draeger Medical’s Global Management Team. His experience includes overseeing large R&D organizations, Product Requirements management, Product Life Cycle Engineering, Operations management and Business Development activities, all in compliance with US and International quality systems and regulations.

Who should attend?

  • Entrepreneurs
  • Early-stage Companies
  • Medical Device Inventors and Medical Researchers
  • Medical Product Manufacturers
  • Suppliers to Medical Device Companies



A light lunch will be available

Please register by October 8, 2012

Return to Top

MEDTECH 2012 Annual Conference

9/24/12-9/25/12 (M -T)

Hyatt Regency, Rochester, NY

Limited registrations are now available on-site on Monday (9/24) and Tuesday (9/25) at the following rates, with no exceptions:

On-site Registration Rates (9/24/12 & 9/25/12)

> MedTech members: $320.00
> Non-members: $395.00

The Upside of Change: Succeeding in the Face of Uncertainty

We all have individual roles to play in the transformation of the healthcare market. This year’s conference will address the pressing issues that keep us up at night.

MEDTECH 2012 will focus on finding opportunity in the transformation of the healthcare industry, and our roles as agents of change.

MEDTECH 2012 is the premier leadership conference and technology showcase of Upstate New York’s bioscience and medical technology industry. This annual conference fuses the region’s abundant capabilities and expertise into a full, energetic gathering of talented professionals.

Sponsorship and exhibiting opportunities are available now.

September 24-25

Hyatt Regency Rochester

125 East Main Street
Rochester, NY 14604


For more conference details, visit the MEDTECH 2012 conference site!

Return to Top

Bioventure Luncheon Series | Building Business Valuation: Recruiting & Building an “A-Team” Workforce

6/20/12 (W) 12:00 - 1:30 pm

Rochester Bioventure Center, 77 Ridgeland Road, Rochester, NY

The greatest value in most companies leaves the building every night—it’s the people that make it all work, or not.  Recruiting, training, retaining, and motivating the people at all levels of an organization makes all the difference in building value for long-term success.

This session includes advice from entrepreneurs, human resource specialists, and technical recruiters that will provide insights on the best practices for building the human capital assets of your business.


Rob Anstey,CEO, Graphene Devices Ltd.

Rob is a NYS licensed attorney and a multifaceted manager focused on business development, strategic partnerships, investment relations, and product development vision. He is also the lead grant writer/manager with almost $1 million in grants and contracts awarded in the last 12 months.  His company, Graphene Devices Ltd., is optimizing productions of graphene, a carbon nanomaterial that can enhance the strength of compounds, including plastics, inks and coatings.

Brian Carroll, Branch Manager, Superior Group

Brian's expertise includes a thorough knowledge of the Staffing Industry, Payroll and Human Resources, Labor Management, Tax Compliance as well as Benefits Administration.  His company, Superior Group, is a Global Workforce Solutions provider that gives their clients the ability to maximize the return on investment into their contingent workforce by providing the best possible workforce output at the lowest cost.

Luis Martínez, CEO, Human Capital Strategy Partners

Luis has been a trusted executive coach and advisor for many years.  His strategic management consulting firm offers leadership development services to organizations and executives.  While in Xerox, Luis directed global human resources functions for Worldwide Manufacturing.  He had been SVP of HR at Lehigh Valley Hospital and VP & GM of Exide Batteries in Puerto Rico.  Luis has a B.A. and M.Ed., from the University of Delaware.  Born and raised in Cuba, Luis has authored two career development books, Getting There and Getting There Volume 2.


Early-stage companies, medical device inventors, and medical researchers that are considering developing new medical devices and entrepreneurs seeking to expand their human capital assets.



A light lunch will be available

Register by June 19, 2012 using the link below

Return to Top

2012 MedTech Annual Members Dinner

6/7/2012 (TH)

Turning Stone Resort and Casino, Verona, NY


Join fellow members and industry leaders from across the state to celebrate a year of accomplishments and to look toward the association's coming year.


MedTech's Annual Members Dinner is a celebration of the contributions and achievements of the bioscience and medical technology community in Upstate New York and a networking opportunity for Bio/Med professionals:

  • Industry leaders and executives
  • Entrepreneurs
  • Researchers and faculty
  • Industry suppliers and services
  • Investors
  • Elected and appointed leaders in government and the community



Cocktails & hors d'oeuvres 6:00-6:30pm

Dinner, speakers & awards

  • State of the Association
    • Heather Erickson, President, MedTech
  • State of the State
    • Bob Duffy, Lt. Governor, State of NY
  • State of the Industry
    • Joe DeVivo, President & CEO, AngioDynamics


Special Guest Speakers:

  • Lt. Governor Robert (Bob) J. Duffy 

    Elected Lieutenant Governor in November 2010, Bob Duffy plays a key role in revitalizing the Upstate economy and leads the state's allocation of funding through the Regional Economic Development Councils and Consolidated Funding Application.

  • Joe DeVivo, President & CEO, AngioDynamics

    As President and CEO of AngioDynamics, Joe DeVivo has demonstrated strong decision-making skills that many of his colleagues have come to admire. Hear more from DeVivo himself when he speaks to the dynamics that are driving the decisions of industry leaders in the region.

Take advantage of business development and networking opportunities beforehand via the MedTech Golf Tournament or Finger Lakes Wine Tour. 


Golf Tournament -  Kaluhyat Golf Club at turning stone

Check-in 11:30am
Driving range and putting green 11:30am-12:30pm
Box Lunch Served at start
Shotgun start and tournament 12:30-6:00pm


Finger Lakes Wine Tour -  Cayuga Lake Wine Trail

Check-in 11:30am
Luxury Coach Departs from Turning Stone 12:00pm
Box Lunch Served at departure
Tour 3 award-winning NYS Wineries 12:00-6:00pm


*ID REQUIRED at wineries



View opportunities for added recognition (click here to download PDF)


Dinner Hosts:

 Polymer Conversions

Eagle Sponsors:

Key Bank


Golf Course Hosts:

Dinner Refreshments Sponsor:


Awards Sponsors:

SUNY Research Foundation

Vallorbs Jewel Company

Return to Top

BioVenture Luncheon Series:Sustainable Design for Medical Devices

5/16/2012 (W) 12:00-1:30pm

Rochester BioVenture Center 77 Ridgeland Road, Rochester, NY

Responding to the Market Demand for "Green" Medical Devices

With increased social and regulatory pressures to reduce waste, particularly medical wastes, now is the time to understand and adopt sustainable practices for the design and manufacture of medical devices.  Embracing sustainable practices now will give your company advantages in product differentiation as well as in increased profits that often result from taking a systems view of a product’s life cycle.

This session includes presentations from practitioners in academia and industry that will share their insights on practices that can be used to improve sustainability, as well as profitability, for new medical devices.


Dr. Anahita Williamson, Director, NYS Pollution Prevention Institute at RIT

  • Expertise in Manufacturing Process Modification for Improved Material Recovery  and Reuse, Design for the Environment, Life-cycle Assessment

Ian Edwards, Senior Director, Corporate Technology Officer, Welch Allyn, Inc.

  • Expertise in early stage diagnostic device concepts and industrial design portfolio management

Who should attend:

  • Entrepreneurs
  • Early-stage Companies
  • Medical Device Inventors and Medical Researchers
  • Medical Product Manufacturers
  • Suppliers to Medical Device Companies

FREE to attend; Registration is required
Light lunch will be available


Space is limited so register early!
Click below to register by Monday, May 14, 2012


Return to Top

Clinical Connections: Laboratory Diagnostics

5/9/12 (W) 4:30 - 7:00 pm

Syracuse, NY

Part of a series of events connecting MedTech members with the clinical community. These informal conversations will cover areas of shared interest, clinical problems that are unmet or under-met, and potential joint research and development projects. Participation is limited to MedTech members. Contact Heather Erickson for more information.

Return to Top

MedTech Institute | Bridging Regulatory Hurdles in the Growing Asia-Pacific Market

4/19/12 (TH) 9:00am-3:00pm

Bausch + Lomb Global Eye Health Center, 1400 N. Goodman Street, Area 67 A&B Training Room, Rochester, NY

The Asia Pacific (APAC) medical devices market is estimated at $55 billion--about one quarter of the global medical devices market. Regulatory policies are becoming more stringent in most APAC countries to facilitate the growth of the medical devices market, which is projected to grow more than 10 percent over the next three years. APAC is one of the fastest growing health markets in the world, and a tremendous opportunity for medical device spending

This workshop will address regulatory compliance and strategies for bringing products to the Asia Pacific market.

Program overview:

Part 1: Regulatory Considerations and Strategies for China

Presented by: Carestream Health, Inc.

In order to place a medical device or diagnostic product on market in China, manufacturers must conform to applicable Chinese standards, comply with Chinese product testing requirements, receive China Compulsory Certification (CCC) from the General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ), and register their products with the State or Provincial Food and Drug Administration. This presentation will cover the initial registration and renewal processes, product testing requirements, using State vs. Provincial regulatory agencies and contract manufacturing.

Part 2: Industry Panel: China

Presented by: Carestream Health, Inc. and Welch Allyn

Industry insights from leading device and diagnostics manufacturers.

Part 3: Regulatory Compliance in Asia

Presented by: Pacific Bridge Medical

A review of the regulatory challenges manufacturers face when trying to register and maintain registration of medical devices in Asia.  The presentation will cover both the current regulatory environment in Asia and anticipated changes over the next few years.  The focus will be on countries other than China and will include an opportunity for Q&A. 

Part 4: Industry Panel: Japan

Presented by: Bausch + Lomb, ConMed Corporation

Industry insights from leading device and diagnostics manufacturers.


Ames Gross, President, Pacific Bridge Medical

Ames Gross is recognized nationally and internationally as a leader in the Asian medical markets. In 2008, Medical Device and Diagnostic Industry (MD&DI) magazine named him one of the top 100 executives in the medical business. Mr. Gross founded Pacific Bridge Medical in 1988 and has helped hundreds of medical companies with business development and regulatory issues in Asia.

Expert Panelists:

  • Jessie Verna, Director, Regulatory Affairs, ConMed Corporation
  • Lisa Anderson, RA Manager, ConMed Corporation
  • Xiaoping Li, China Compliance Director, Carestream Health, Inc.
  • Kevin Crossen, Director, Regulatory Affairs, Welch Allyn
  • Jennifer Murray, Manager, Global Regulatory Affiars, Bausch+Lomb
  • Helen Sun, Associate Director, Regulatory Affairs, Bausch+Lomb


Sponsored By:



Return to Top

Understanding the Physician Payments Sunshine Act

4/11/12 (W) 12:00-1:00pm EST


Special member-only event

FREE for all MedTech Members - Registration required, please follow the link below to register

In December 2011, CMS released the Proposed Rule to implement the Sunshine Act which requires public disclosure of payments made by pharmaceutical, device, medical and biological supply companies to physicians and teaching hospitals for a wide array of purposes, including consulting, royalty payments and travel. 

Attend this webcast to learn from our expert about:

  • Which manufacturers must report under the Sunshine Act Proposed Rule, what information must be reported about payments and in what detail?
  • What information will be publicly disclosed about payments?
  • What steps can life science companies take to prepare for public transparency of payments under the Sunshine Act?


Registred attendees will be sent Webinar call-in information on Tuesday, April 10th.



Return to Top

The Secrets of Successful Valuation, Exit & Investment Strategies

4/4/2012 (W) 12:30 - 6:00 pm

NYS Center of Excellence in Bioinformatics & Life Sciences, 701 Ellicott Street, Buffalo, NY

Setting the stage for the 2012 Venture Forum (May 16-17, Buffalo, NY)

How are angel, venture capital and corporate investment deals made across high-tech sectors? Hear what experts have to say about the growth capital landscape and determine your internal investment strategy. This half-day program will provide information on the current investment climate and how you can establish rewarding relationships with investors.

The program includes a networking luncheon sponsored by UVANY and closing networking reception sponsored by Superior Group.

The Material:

  • Funding trends and deal structure
  • Valuation models
  • Exit Strategies for founders, owners and investors
  • Corporate strategic investments and acquisitions

The Experts:

  • Stacey Davis, Johnson & Johnson
  • Teo Balbach, Mercury Capital Partners
  • Louis Camarella, EFP Rotenberg LLP
  • Jack McGowan, Western New York Venture Association (WNYVA)
  • Dan Penberthy, Rand Capital Corp, Upstate Venture Association (UVANY)
  • Ari David Kocen, Stonehenge Growth Capital
  • Kurt Litzelfelner, StoneBridge Business Partners

Who should attend?

  • Companies planning to present at the 2012 Venture Forum
  • Successful entrepreneurs who have exited their businesses
  • High net-worth individuals with interest in angel investing
  • Service providers that support early stage, high-tech businesses
  • Economic development professionals
  • Incubator and business innovation professionals

In partnership with:


With support from:




Return to Top

Today Is:
Monday, October 20, 2014

October Events

<< >>